An Update on Immunotherapy in Liver Cancer

An Update on Immunotherapy in Liver Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: Recent Advances in the Treatment of Liver Cancer

February 27th 2018

EP. 2: Hepatocellular Carcinoma: Immunotherapy After Sorafenib

February 27th 2018

EP. 3: Hepatocellular Carcinoma: Recent Approval of Nivolumab

February 27th 2018

EP. 4: KEYNOTE-224: Improving HCC Outcomes With Pembrolizumab

February 27th 2018

EP. 5: Optimizing Checkpoint Inhibitor Combinations in HCC

February 27th 2018

EP. 6: Hepatocellular Carcinoma: Future Role of Immunotherapy

February 27th 2018

Trending on OncLive

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Mo-Rez Advances Into Combination Studies Following Robust Responses in Gynecologic Cancers

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors